Recalibrating the urine output criteria for acute kidney injury: stage-specific thresholds matched to creatinine-stage-derived mortality - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Aligning Urine Output Thresholds for Acute Kidney Injury Stages With Creatinine-Based Mortality Risk

  • By

  • Annelie Barrueta Tenhunen

  • Rasmus Mossberg

  • Miklos Lipcsey

  • Mikael Eriksson

  • Michael Marks-Hultström

  • October 28, 2026

Share

Objective:

To identify urine-output thresholds associated with mortality equivalent to creatinine-defined KDIGO AKI stages.

Approach:
  • Cohort: Reanalysis of 5,698 ICU admissions involving 4,999 adults without pre-existing chronic kidney disease at one Swedish general ICU.
  • Analysis: Minimum sustained urine output was assessed over overlapping 3-, 6-, 12-, and 24-hour intervals. Age- and sex-adjusted models estimated its association with 14-day mortality.
Key Findings:
  • Under current KDIGO urine-output criteria, mortality was underestimated by 37% at stage 1 and 48% at stage 2, and overestimated by 34% at stage 3, relative to creatinine-defined staging.
  • Mortality-equivalent urine-output thresholds were identified for each creatinine-defined stage over 3-, 6-, and 12-hour intervals. For 24-hour intervals, thresholds were identified for stages 1 and 2, but not stage 3.
  • All identified thresholds were below the current stage 1 cutoff of 0.5 mL/kg/h.
  • Urine output below 0.24 mL/kg/h sustained for 3 hours was associated with mortality equivalent to creatinine-defined stage 1 AKI.
Interpretation:

The authors report discordance between current urine-output staging and creatinine-defined mortality risk. The proposed thresholds are prognostic, not causal.

Limitations:
  • The analysis involved a single tertiary-care ICU and requires validation in other settings and ICU populations.
  • Adjustment included only age and sex; residual confounding cannot be excluded.
  • Diuretic use, fluid status, and continuous renal replacement therapy were not considered.
  • No corresponding analysis of tissue-injury markers was conducted.
Conclusion:

The study identifies urine-output thresholds aligned with creatinine-defined mortality risk and reports that current criteria underestimate mortality at stages 1 and 2 and overestimate it at stage 3. The authors present the thresholds as a reference for future validation.

Original Source(s)

Related Content